Markers of bone resorption in bisphosphonate therapy of Paget's disease.
E
E
Cacace
V
V
Ruggiero
C
C
Matulli
L
L
Uras
G
G
Perpignano
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D015415:Biomarkers / Q000032:analysis*; D001862:Bone Resorption / Q000188:drug therapy / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003094:Collagen / Q000097:blood / Q000652:urine; D024042:Collagen Type I; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010145:Paget Disease, Extramammary / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D010455:Peptides / Q000097:blood / Q000652:urine; D000068296:Risedronic Acid
D015415:Biomarkers; D002121:Calcium Channel Blockers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D003094:Collagen; D000469:Alkaline Phosphatase; D000068296:Risedronic Acid; D012968:Etidronic Acid